| Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
| Ethacrynate sodium |
Is a |
False |
Etacrynic acid (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Ethacrynic acid poisoning (disorder) |
Causative agent (attribute) |
True |
Etacrynic acid (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Ethacrynic acid adverse reaction |
Causative agent (attribute) |
True |
Etacrynic acid (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Ethacrynic acid allergy |
Causative agent (attribute) |
False |
Etacrynic acid (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Ethacrynic acid overdose |
Causative agent (attribute) |
True |
Etacrynic acid (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Accidental ethacrynic acid overdose |
Causative agent (attribute) |
True |
Etacrynic acid (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Intentional ethacrynic acid overdose |
Causative agent (attribute) |
True |
Etacrynic acid (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Ethacrynic acid overdose of undetermined intent |
Causative agent (attribute) |
False |
Etacrynic acid (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Etacrynic acid 25 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Etacrynic acid (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Product containing precisely etacrynic acid 50 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Etacrynic acid (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Poisoning by ethacrynic acid |
Causative agent (attribute) |
False |
Etacrynic acid (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Etacrynic acid-containing product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Etacrynic acid (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Ethacrynate measurement |
Component |
True |
Etacrynic acid (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Ethacrynic acid allergy |
Causative agent (attribute) |
True |
Etacrynic acid (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Etacrynic acid 25 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Etacrynic acid (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Etacrynic acid 25 mg oral tablet |
Has basis of strength substance (attribute) |
True |
Etacrynic acid (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Product containing precisely etacrynic acid 50 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Etacrynic acid (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Product containing precisely etacrynic acid 50 milligram/1 each conventional release oral tablet (clinical drug) |
Has basis of strength substance (attribute) |
True |
Etacrynic acid (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Ethacrynate sodium |
Is modification of (attribute) |
True |
Etacrynic acid (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Etacrynic acid 25 mg oral tablet |
Has precise active ingredient |
True |
Etacrynic acid (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Product containing precisely etacrynic acid 50 milligram/1 each conventional release oral tablet (clinical drug) |
Has precise active ingredient |
True |
Etacrynic acid (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Etacrynic acid-containing product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Etacrynic acid (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Etacrynic acid only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Etacrynic acid (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Product containing only etacrynic acid in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Etacrynic acid (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Etacrynic acid only product in parenteral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Etacrynic acid (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Product containing etacrynic acid in parenteral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Etacrynic acid (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
FHIR
© HL7.org
|
Server Home |
FHIR Server FHIR Server 3.7.4-SNAPSHOT
|
FHIR Version n/a
User: [n/a]